The obesity GLP-1 market is expected to grow at a 23.1% CAGR between 2025 and 2035
On one hand, tissue delivery is substantially higher per mole of peptide injected
Include details such as: How much each employee receives The timeframe for spending and whether funds roll over Any maximum rollover or forfeit dates Which categories are included How to submit expenses Any tax implications Where to go for questions Open communication with your team is one of the most important steps in making your LSA program a success
At a glance Platform type / Women-focused GLP-1 telehealth + dietitian coaching Primary medication / Semaglutide (oral or injectable, dose-titrated) Regulatory basis / GLP-1 prescribing follows FDA-approved indications for BMI 30 or BMI 27 with a weight-related comorbidity Hard contraindications / Personal or family history of MTC or MEN2, pregnancy, active anorexia or bulimia Key safety signal / GLP-1 agents carry an FDA boxed warning for thyroid C-cell tumors in rodents Complaint pattern / Most documented complaints relate to cancellation difficulty and billing, not clinical harm Trial benchmark / STEP-1 (N=1,961): semaglutide 2.4 mg produced 14.9% mean body-weight loss at 68 weeks vs
This is the same pathway activated by UV exposure, but MT-2 amplifies it far beyond what sunlight alone achieves
Tendon and ligament repair in specific locations
